Loading…
Immunosuppressive Drug Coverage Act of 2003
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,018 other S bills in the 108th — cohort avg 48d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
H.R.2218 Regulation of non corrective contact lens as medical devices S.1 Prescription Drug and Medicare Improvement Act of 2003 H.R.1 Medicare Prescription Drug Modernization Act of 2003 H.R.2427 Pharmaceutical Market Access Act of 2003 H.R.1288/S.1037 Access to Cancer Therapies Act of 2003 S.178 Comprehensive Immunosuppressive Drug Coverage for Transplant patients Act of 2003 S.191/H.R.2223 Immunosuppressive drug Coverage Act of 2003 H.R.2356 Prescription Drug Comparative Effectiveness Act of 2003 S.650/H.R.2857 Pediatric Research Equity Act of 2003 H.R.2769 Save our Seniors Act of 2003 H.R.2427 Pharmaceutical Market Access Act of 2003 H.R.1170 Child Medication Safety Act of 2003 H.R.2218 Federal Food, Drug, and Cosmetic Act Medicare Prescription Drugs Breaux/Thomas Medicare Reform Plan Health Insurance Portability and Accessibility Act FDA Modernization Act Medical Records Privacy - Senator jeffords, Bennett, Leahy, Kennedy bills Prospective Payment system Gene Therapy Drug Reimportation Medicare Reform Agriculture Appropriation 2001 - Drug Reimportation Agriculture Appropriation 2001 (FDA Funding) Stem Cell Research Pediatric Exclusivity Direct-to-Consumer Advertising The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill)
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $1,640,102 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.2218 Regulation of non corrective contact lens as medical devices S.1 Prescription Drug and Medicare Improvement Act of 2003 H.R.1 Medicare Prescription Drug Modernization Act of 2003 H.R.2427 Pharmaceutical Market Access Act of 2003 H.R.1288/S.1037 Access to Cancer Therapies Act of 2003 S.178 Comprehensive Immunosuppressive Drug Coverage for Transplant patients Act of 2003 S.191/H.R.2223 Immunosuppressive drug Coverage Act of 2003 H.R.2356 Prescription Drug Comparative Effectiveness Act of 2003 S.650/H.R.2857 Pediatric Research Equity Act of 2003 H.R.2769 Save our Seniors Act of 2003 H.R.2427 Pharmaceutical Market Access Act of 2003 H.R.1170 Child Medication Safety Act of 2003 H.R.2218 Federal Food, Drug, and Cosmetic Act S.874/H.R.1736 Sickle Cell Treatment Act Medicare Prescription Drugs Breaux/Thomas Medicare Reform Plan Health Insurance Portability and Accessibility Act FDA Modernization Act Medical Records Privacy - Senator jeffords, Bennett, Leahy, Kennedy bills Prospective Payment system Gene Therapy Drug Reimportation Medicare Reform Agriculture Appropriation 2001 - Drug Reimportation Agriculture Appropriation 2001 (FDA Funding) Stem Cell Research Pediatric Exclusivity Direct-to-Consumer Advertising The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill)
Client expense: $1,958,138 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.2218, Regulation of non corrective contact lens as medical devices S.1, Prescription Drug and Medicare Improvement Act of 2003 H.R.1, Medicare Prescription Drug Modernization Act of 2003 H.R.2427, Pharmaceutical Market Access Act of 2003 HR1288/S1037, Access to Cancer Therapies Act of 2003 S178, Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003 S191/HR2223, Immunosuppressive Drug Coverage Act of 2003 HR588, Medicare Fairness for Organ Transplant Recipients Act of 2003 HR2356, Prescription Drug Comparative Effectiveness Act of 2003 S.650/HR2857, Pediatric Research Equity Act of 2003 HR2769, Save our Seniors Act of 2003 HR2427 Pharmaceutical Market Access Act of 2003 HR1170, Child Medication Safety Act of 2003 Medicare Prescription Drugs Breaux/Thomas Medicare Reform Plan Health Insurance Portability and Accessibility Act FDA Modernization Act Medical Records Privacy – Senators Jeffords, Bennett, Leahy, Kennedy Bills Prospective Payment System Gene Therapy Drug Reimportation Medicare Reform Agriculture appropriation 2001 – Drug Reimportation Agriculture appropriation 2001 (FDA funding) Stem Cell Research Pediatric Exclusivity Direct-to-Consumer Advertising The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill)
Client expense: $1,479,577 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.2218, Regulation of non corrective contact lens as medical devices S.1, Prescription Drug and Medicare Improvement Act of 2003 H.R.1, Medicare Prescription Drug Modernization Act of 2003 H.R.2427, Pharmaceutical Market Access Act of 2003 HR1288/S1037, Access to Cancer Therapies Act of 2003 S178, Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003 S191/HR2223, Immunosuppressive Drug Coverage Act of 2003 HR588, Medicare Fairness for Organ Transplant Recipients Act of 2003 HR2356, Prescription Drug Comparative Effectiveness Act of 2003 S.650, Pediatric Research Equity Act of 2003 HR2769, Save our Seniors Act of 2003 HR2427 Pharmaceutical Market Access Act of 2003 HR2857, Pediatric Research Equity Act of 2003 HR1170, Child Medication Safety Act of 2003 Medicare Prescription Drugs & Modfernization Act The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill) Prospective Payment System Medicare Reform
Client expense: $1,479,577 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.2218 Regulation of non corrective contact lens as medical devices S.1 Prescription Drug and Medicare Improvement Act of 2003 H.R.1 Medicare Prescription Drug Modernization Act of 2003 H.R.2427 Pharmaceutical Market Access Act of 2003 H.R 1288/S.1037 Access to Cancer Therapies Act of 2003 S.178 Comprehensive Immunospuppressive Drug Coverage for Transplant patients Act of 2003 S.191/H.R.2223 Immunosuppressive drug Coverage Act of 2003 H.R.588 Medicare Fairness for Organ Transplant Recipients Act of 2003 H.R.2356 Prescription Drug Comparative Effectiveness Act of 2003 S.650/H.R.2857 Pediatric Research Equity Act of 2003 H.R.2769 Save our Seniors Act of 2003 H.R.2427 Pharmaceutical Market Access Act of 2003 H.R. 1170 Child Medication Safety Act of 2003 H.R.2218 Federal Food, Drug, and Cosmetic Act Medicare Prescription Drugs Breaux/Thomas Medicare Reform Plan Health Insurance Portability and Accessibility Act FDA Modernization Act Medical Records Privacy - Senator Jeffords, Bennett, Leahy, Kennedy Bills Prospective Payment System Gene Therapy Drug Reimportation Medicare Reform Agriculture Appropriation 2001 - Drug Reimportation Agriculture Appropriation 2001 (FDA Funding) Stem Cell Research Pediatric Exclusivity Direct-to-Consumer Advertising The Bipartisan Medicare Prescription Drug Act of 2001 (Sen.Kennedy-Draft Bill)
Client expense: $1,474,129 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.2218, Regulation of non corrective contact lens as medical devices S.1, Prescription Drug and Medicare Improvement Act of 2003 H.R.1, Medicare Prescription Drug Modernization Act of 2003 H.R.2427, Pharmaceutical Market Access Act of 2003 HR1288/S1037, Access to Cancer Therapies Act of 2003 S178, Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003 S191/HR2223, Immunosuppressive Drug Coverage Act of 2003 HR588, Medicare Fairness for Organ Transplant Recipients Act of 2003 HR2356, Prescription Drug Comparative Effectiveness Act of 2003 S.650, Pediatric Research Equity Act of 2003 HR2769, Save our Seniors Act of 2003 HR2427 Pharmaceutical Market Access Act of 2003 HR2857, Pediatric Research Equity Act of 2003 HR1170, Child Medication Safety Act of 2003 Medicare Prescription Drugs & Modfernization Act The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill) Prospective Payment System Medicare Reform
Client expense: $1,479,577 · Firm income: Not reported
H.R.2218, Regulation of non corrective contact lens as medical devices S.1, Prescription Drug and Medicare Improvement Act of 2003 H.R.1, Medicare Prescription Drug Modernization Act of 2003 H.R.2427, Pharmaceutical Market Access Act of 2003 HR1288/S1037, Access to Cancer Therapies Act of 2003 S178, Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003 S191/HR2223, Immunosuppressive Drug Coverage Act of 2003 HR588, Medicare Fairness for Organ Transplant Recipients Act of 2003 HR2356, Prescription Drug Comparative Effectiveness Act of 2003 S.650/HR2857, Pediatric Research Equity Act of 2003 HR2769, Save our Seniors Act of 2003 HR2427 Pharmaceutical Market Access Act of 2003 HR1170, Child Medication Safety Act of 2003 Medicare Prescription Drugs Breaux/Thomas Medicare Reform Plan Health Insurance Portability and Accessibility Act FDA Modernization Act Medical Records Privacy – Senators Jeffords, Bennett, Leahy, Kennedy Bills Prospective Payment System Gene Therapy Drug Reimportation Medicare Reform Agriculture appropriation 2001 – Drug Reimportation Agriculture appropriation 2001 (FDA funding) Stem Cell Research Pediatric Exclusivity Direct-to-Consumer Advertising The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill)
Client expense: $1,479,577 · Firm income: Not reported
2003 · year_end · Health Issues
H.R.1784 - Medicare Renal Dialysis Payment Fairness Act of 2003. H.R.1004 - Kidney Patient Daily Dialysis Quality Act of 2003. S.191 - Immunosuppresive Drug Coverage Act of 2003. H.R.128 - Medicare Coverage of Replacement Calcitrol Act of 2003. S.114 - Kidney Disease Educational Benefits Act f 2003. S.1./H.R.1 - Prescription Drug and Medicare Act of 2003. H.R. 3635 - Medicare Chronic Kidney Disease Management Act of 2003. S.1781/H.R.2223 - Comprehensive Immuno Suppresive Drug Coverage for Transplant Patients Act of 2003. S.11 - Patients First Act Of 2003. S.607/H.R.5 - Health Act of 2003.
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2003 · mid_year · Health Issues
H.R.1784 - Medicare Renal Dialysis Payment Fairness Act of 2003. H.R.1004 - Kidney Patient Daily Dialysis Quality Act of 2003. S.191/S.178 - Immunosuppresive Drug Coverage Act of 2003 H.R.810 - Medicare Regulatory & Contracting Reform Act of 2003. H.R.128 - Medicare Coverage of Replacement Calcitrol Act of 2003. S.1114 - Kidney Disease Educational Benefits Act of 2003 S.1/H.R.1- Prescription Drug and Medicare Act of 2003.
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.R.2218, Regulation of non corrective contact lens as medical devices S.1, Prescription Drug and Medicare Improvement Act of 2003 H.R.1, Medicare Prescription Drug Modernization Act of 2003 H.R.2427, Pharmaceutical Market Access Act of 2003 HR1288/S1037, Access to Cancer Therapies Act of 2003 S178, Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003 S191/HR2223, Immunosuppressive Drug Coverage Act of 2003 HR588, Medicare Fairness for Organ Transplant Recipients Act of 2003 HR2356, Prescription Drug Comparative Effectiveness Act of 2003 S.650, Pediatric Research Equity Act of 2003 HR2769, Save our Seniors Act of 2003 HR2427 Pharmaceutical Market Access Act of 2003 HR2857, Pediatric Research Equity Act of 2003 HR1170, Child Medication Safety Act of 2003 Medicare Prescription Drugs & Modfernization Act The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill) Prospective Payment System Medicare Reform
Client expense: $1,479,577 · Firm income: Not reported
H.R.2218, Regulation of non corrective contact lens as medical devices S.1, Prescription Drug and Medicare Improvement Act of 2003 H.R.1, Medicare Prescription Drug Modernization Act of 2003 H.R.2427, Pharmaceutical Market Access Act of 2003 HR1288/S1037, Access to Cancer Therapies Act of 2003 S178, Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003 S191/HR2223, Immunosuppressive Drug Coverage Act of 2003 HR588, Medicare Fairness for Organ Transplant Recipients Act of 2003 HR2356, Prescription Drug Comparative Effectiveness Act of 2003 S.650/HR2857, Pediatric Research Equity Act of 2003 HR2769, Save our Seniors Act of 2003 HR2427 Pharmaceutical Market Access Act of 2003 HR1170, Child Medication Safety Act of 2003 Medicare Prescription Drugs Breaux/Thomas Medicare Reform Plan Health Insurance Portability and Accessibility Act FDA Modernization Act Medical Records Privacy – Senators Jeffords, Bennett, Leahy, Kennedy Bills Prospective Payment System Gene Therapy Drug Reimportation Medicare Reform Agriculture appropriation 2001 – Drug Reimportation Agriculture appropriation 2001 (FDA funding) Stem Cell Research Pediatric Exclusivity Direct-to-Consumer Advertising The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill)
Client expense: $1,479,577 · Firm income: Not reported
H.R.2218, Regulation of non corrective contact lens as medical devices S.1, Prescription Drug and Medicare Improvement Act of 2003 H.R.1, Medicare Prescription Drug Modernization Act of 2003 H.R.2427, Pharmaceutical Market Access Act of 2003 HR1288/S1037, Access to Cancer Therapies Act of 2003 S178, Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003 S191/HR2223, Immunosuppressive Drug Coverage Act of 2003 HR588, Medicare Fairness for Organ Transplant Recipients Act of 2003 HR2356, Prescription Drug Comparative Effectiveness Act of 2003 S.650/HR2857, Pediatric Research Equity Act of 2003 HR2769, Save our Seniors Act of 2003 HR2427 Pharmaceutical Market Access Act of 2003 HR1170, Child Medication Safety Act of 2003 Medicare Prescription Drugs Breaux/Thomas Medicare Reform Plan Health Insurance Portability and Accessibility Act FDA Modernization Act Medical Records Privacy – Senators Jeffords, Bennett, Leahy, Kennedy Bills Prospective Payment System Gene Therapy Drug Reimportation Medicare Reform Agriculture appropriation 2001 – Drug Reimportation Agriculture appropriation 2001 (FDA funding) Stem Cell Research Pediatric Exclusivity Direct-to-Consumer Advertising The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill)
Client expense: $1,479,577 · Firm income: Not reported
H.R.2218, Regulation of non corrective contact lens as medical devices S.1, Prescription Drug and Medicare Improvement Act of 2003 H.R.1, Medicare Prescription Drug Modernization Act of 2003 H.R.2427, Pharmaceutical Market Access Act of 2003 HR1288/S1037, Access to Cancer Therapies Act of 2003 S178, Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003 S191/HR2223, Immunosuppressive Drug Coverage Act of 2003 HR588, Medicare Fairness for Organ Transplant Recipients Act of 2003 HR2356, Prescription Drug Comparative Effectiveness Act of 2003 S.650, Pediatric Research Equity Act of 2003 HR2769, Save our Seniors Act of 2003 HR2427 Pharmaceutical Market Access Act of 2003 HR2857, Pediatric Research Equity Act of 2003 HR1170, Child Medication Safety Act of 2003 Medicare Prescription Drugs & Modfernization Act The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill) Prospective Payment System Medicare Reform
Client expense: $1,479,577 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE